TANC2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 8.6014528832834E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.34330000351102E-08 |
Normal-vs-Stage2 |
7.976300E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.042270E-02 |
Stage1-vs-Stage2 |
1.408360E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.788400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.762400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.94689947391669E-10 |
Normal-vs-AfricanAmerican |
1.601020E-01 |
Normal-vs-Asian |
8.259900E-02 |
Caucasian-vs-AfricanAmerican |
8.243200E-01 |
Caucasian-vs-Asian |
1.303630E-01 |
AfricanAmerican-vs-Asian |
5.058400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.59891999998996E-05 |
Normal-vs-Female |
3.43149999970649E-07 |
Male-vs-Female |
9.284800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.956000E-03 |
Normal-vs-Extreme_Weight |
2.67610000004304E-06 |
Normal-vs-Obese |
3.364700E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.813400E-01 |
Normal_Weight-vs-Obese |
8.173000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.278400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.910250E-01 |
Normal-vs-Age(41-60Yrs) |
4.16650000001351E-06 |
Normal-vs-Age(61-80Yrs) |
1.5689000000263E-06 |
Normal-vs-Age(81-100Yrs) |
2.840600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.056040E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.316600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.538000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.154600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.831200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.024200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.138000E-01 |
Normal-vs-Grade 3 |
4.768800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.462400E-01 |
Grade 2-vs-Grade 4 |
6.138000E-01 |
Grade 3-vs-Grade 4 |
4.768800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.62370000462198E-09 |
Normal-vs-N1 |
1.649680E-02 |
N0-vs-N1 |
2.312000E-01 |
|
|